Update: AUKUS Milestone: Export License Requirements for Australia and the UK Significantly Eased through US Department of Commerce Interim Final Rule, and US State Department Issues Proposed New ITAR Exemption

The following is an updated version of an advisory first issued on April 30. The original advisory addressed only the Department of Commerce Interim Final Rule. It has been updated to address the subsequent Department of State Proposed Rule.  In accordance with the...

Cannabis Industry Client Alert

The United States Drug Enforcement Administration (“DEA”) has announced its intention to reclassify cannabis from a Schedule I to Schedule III drug, a move with quite significant potential consequences. This reclassification would profoundly alter the risk of use of...